Mathieu Chevrier

Stock Analyst at Citigroup

(0.02)
# 3,527
Out of 4,479 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:

1 Stocks

ResMed
Jun 24, 2024
Downgrades: Neutral
Price Target: n/a
Current: $189.35
Upside: -